The second potential adverse outcome is hyperinflammation, characterized by high levels of C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor alpha (TNF-α), which can increase the risk of PLWH developing acute respiratory distress syndrome (ARDS) [3,6,7]. The gene discussed is IL6; the disease is acute respiratory distress syndrome.